Litcius/Paper detail

NAFLD and NASH: etiology, targets and emerging therapies

Shulin Wei, Li Wang, Paul C. Evans, Suowen Xu

2024Drug Discovery Today184 citationsDOI

Topics & Concepts

SteatohepatitisFatty liverMedicineBioinformaticsFibrosisDiseaseBiologyInternal medicineLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseFibroblast Growth Factor Research
NAFLD and NASH: etiology, targets and emerging therapies | Litcius